![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Chidiac, TE Hebert, M Valiquette, M Dennis and M Bouvier
Departement de biochimie, Universite de Montreal, Canada.
Agonist-independent properties of the human beta 2-adrenergic receptor (beta 2AR) were studied using the baculovirus expression system in Sf9 cells. In the absence of agonist but in the presence of GTP, membranes from cells expressing the beta 2AR exhibited higher levels of cAMP production than did membranes from uninfected cells or from cells infected with wild-type baculovirus. The increase in cAMP production was proportional to the number of beta 2AR expressed, up to 40 pmol/mg of membrane protein, and it could be inhibited in a dose-dependent manner by beta AR antagonists. The increase and its reversal both were independent of the possible presence of contaminating catecholamines in the culture medium and thus appear to reflect spontaneous beta 2AR activity and direct antagonist-receptor interactions, respectively. The maximal level of inhibition varied among the beta AR ligands tested, to yield the following rank order of "inverse efficacy"; timolol > or = propranolol > alprenolol > or = pindolol > labetalol > dichloroisoproterenol. The same rank order was observed using membranes prepared from Chinese hamster fibroblasts expressing beta 2AR. The effect of timolol was partly blocked by labetalol and dichloroisoproterenol, in an apparently competitive manner. The intracellular cAMP content of Sf9 cells cultured in serum-free medium was also increased by the expression of beta 2AR, and that increase was reversed by timolol and propranolol, consistent with observations in membrane preparations. The properties revealed by the expression of the beta 2AR in Sf9 cells suggest two agonist-independent traits of G protein-linked receptors, i.e., 1) that unliganded receptors are able to activate G proteins both in membrane preparations and in whole cells and 2) that antagonists may mediate their effects not only by preventing the binding of agonists but also by decreasing the propensity of the receptor to assume an active state.
This article has been cited by other articles:
|
|
 |
|
  J. Guo, D. J. Williams, H. L. Puhl III, and S. R. Ikeda Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 342 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Boivin, C. Lavoie, G. Vaniotis, A. Baragli, L.-R. Villeneuve, N. Ethier, P. Trieu, B. G. Allen, and T. E. Hebert Functional {beta}-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes Cardiovasc Res, July 1, 2006; 71(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hayashi, S. Osada, M. Yoshiki, D. Sugiyama, I. Fujita, Y. Hamasaki, and H. Kodama Superoxide Production in Human Neutrophils Is Enhanced by Treatment with Transmembrane Peptides Derived from Human Formyl Peptide Receptor J. Biochem., June 1, 2006; 139(6): 981 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Andressen, J. H. Norum, F. O. Levy, and K. A. Krobert Activation of Adenylyl Cyclase by Endogenous Gs-Coupled Receptors in Human Embryonic Kidney 293 Cells Is Attenuated by 5-HT7 Receptor Expression Mol. Pharmacol., January 1, 2006; 69(1): 207 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Baker Evidence for a Secondary State of the Human {beta}3-Adrenoceptor Mol. Pharmacol., December 1, 2005; 68(6): 1645 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ugur, S. S. Oner, P. Molinari, C. Ambrosio, K. Sayar, and H. O. Onaran Guanine Nucleotide Exchange-Independent Activation of Gs Protein by {beta}2-Adrenoceptor Mol. Pharmacol., September 1, 2005; 68(3): 720 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Perez and S. S. Karnik Multiple Signaling States of G-Protein-Coupled Receptors Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Audet, M. Paquin-Gobeil, O. Landry-Paquet, P. W. Schiller, and G. Pineyro Internalization and Src Activity Regulate the Time Course of ERK Activation by Delta Opioid Receptor Ligands J. Biol. Chem., March 4, 2005; 280(9): 7808 - 7816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pineyro, M. Azzi, A. deLean, P. W. Schiller, and M. Bouvier Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human {delta}-Opioid Receptor with an Inverse Agonist Mol. Pharmacol., January 1, 2005; 67(1): 336 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Breit, M. Lagace, and M. Bouvier Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Baker, I. P. Hall, and S. J. Hill Temporal Characteristics of cAMP Response Element-Mediated Gene Transcription: Requirement for Sustained cAMP Production Mol. Pharmacol., April 1, 2004; 65(4): 986 - 998. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Dupre, C. Le Gouill, D. Gingras, M. Rola-Pleszczynski, and J. Stankova Inverse Agonist Activity of Selected Ligands of the Cysteinyl-Leukotriene Receptor 1 J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 102 - 108. [Abstract] [Full Text]
|
|
|
|
|
|
D. Wang, K. M. Raehal, E. T. Lin, J. J. Lowery, B. L. Kieffer, E. J. Bilsky, and W. Sadee Basal Signaling Activity of {micro} Opioid Receptor in Mouse Brain: Role in Narcotic Dependence J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 512 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Prather Inverse Agonists: Tools to Reveal Ligand-Specific Conformations of G Protein-Coupled Receptors Sci. Signal., January 13, 2004; 2004(215): pe1 - pe1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Baker, I. P. Hall, and S. J. Hill Agonist and Inverse Agonist Actions of {beta}-Blockers at the Human {beta}2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling Mol. Pharmacol., December 1, 2003; 64(6): 1357 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chakir, Y. Xiang, D. Yang, S.-J. Zhang, H. Cheng, B. K. Kobilka, and R.-P. Xiao The Third Intracellular Loop and the Carboxyl Terminus of {beta}2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor Mol. Pharmacol., November 1, 2003; 64(5): 1048 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, S. Tokita, and H. Kotani Generation and Characterization of Highly Constitutive Active Histamine H3 Receptors J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 213 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Azzi, P. G. Charest, S. Angers, G. Rousseau, T. Kohout, M. Bouvier, and G. Pineyro {beta}-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors PNAS, September 30, 2003; 100(20): 11406 - 11411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gbahou, A. Rouleau, S. Morisset, R. Parmentier, S. Crochet, J.-S. Lin, X. Ligneau, J. Tardivel-Lacombe, H. Stark, W. Schunack, et al. Protean agonism at histamine H3 receptors in vitro and in vivo PNAS, September 16, 2003; 100(19): 11086 - 11091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Monczor, N. Fernandez, B. L. Legnazzi, M. E. Riveiro, A. Baldi, C. Shayo, and C. Davio Tiotidine, a Histamine H2 Receptor Inverse Agonist That Binds with High Affinity to an Inactive G-Protein--Coupled Form of the Receptor. Experimental Support for the Cubic Ternary Complex Model Mol. Pharmacol., August 1, 2003; 64(2): 512 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schroeder, A. Breit, H. Boning, J. Dedio, L. Gera, J. Stewart, and W. Muller-Esterl Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1924 - H1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hannawacker, C. Krasel, and M. J. Lohse Mutation of Asn293 to Asp in Transmembrane Helix VI Abolishes Agonist-Induced but Not Constitutive Activity of the beta 2-Adrenergic Receptor Mol. Pharmacol., December 1, 2002; 62(6): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Sum, P. S.-H. Park, and J. W. Wells Effects of N-Ethylmaleimide on Conformational Equilibria in Purified Cardiac Muscarinic Receptors J. Biol. Chem., September 20, 2002; 277(39): 36188 - 36203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cladman and P. Chidiac Characterization and Comparison of RGS2 and RGS4 as GTPase-Activating Proteins for m2 Muscarinic Receptor-Stimulated Gi Mol. Pharmacol., September 1, 2002; 62(3): 654 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Mehlmann, T. L. Z. Jones, and L. A. Jaffe Meiotic Arrest in the Mouse Follicle Maintained by a Gs Protein in the Oocyte Science, August 23, 2002; 297(5585): 1343 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Joubert, S. Claeysen, M. Sebben, A.-S. Bessis, R. D. Clark, R. S. Martin, J. Bockaert, and A. Dumuis A 5-HT4 Receptor Transmembrane Network Implicated in the Activity of Inverse Agonists but Not Agonists J. Biol. Chem., July 5, 2002; 277(28): 25502 - 25511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andreka, N. Aiyar, L. C. Olson, J. Q. Wei, M. S. Turner, K. A. Webster, E. H. Ohlstein, and N. H. Bishopric Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium Circulation, May 21, 2002; 105(20): 2429 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Loland, L. Norregaard, T. Litman, and U. Gether Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle PNAS, January 24, 2002; (2002) 32386299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Azzi, G. Pineyro, S. Pontier, S. Parent, H. Ansanay, and M. Bouvier Allosteric Effects of G Protein Overexpression on the Binding of beta -Adrenergic Ligands with Distinct Inverse Efficacies Mol. Pharmacol., November 1, 2001; 60(5): 999 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-P. Xiao {beta}-Adrenergic Signaling in the Heart: Dual Coupling of the {beta}2-Adrenergic Receptor to Gs and Gi Proteins Sci. Signal., October 16, 2001; 2001(104): re15 - re15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Dupre, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova Inverse Agonist Activity of Selected Ligands of Platelet-Activating Factor Receptor J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Port and M. R. Bristow beta -Adrenergic Receptors, Transgenic Mice, and Pharmacological Model Systems Mol. Pharmacol., October 1, 2001; 60(4): 629 - 631. [Full Text] [PDF]
|
|
|
|
|
|
S. Engelhardt, Y. Grimmer, G.-H. Fan, and M. J. Lohse Constitutive Activity of the Human beta 1-Adrenergic Receptor in beta 1-Receptor Transgenic Mice Mol. Pharmacol., October 1, 2001; 60(4): 712 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aubert, J. Guiramand, A. Croce, G. Roch, A. Szafarczyk, and M. Vignes An Endogenous Adrenoceptor Ligand Potentiates Excitatory Synaptic Transmission in Cultured Hippocampal Neurons Cereb Cortex, September 1, 2001; 11(9): 878 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Seifert Monovalent Anions Differentially Modulate Coupling of the beta 2-Adrenoceptor to Gsalpha Splice Variants J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 840 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Seifert, K. Wenzel-Seifert, U. Gether, and B. K. Kobilka Functional Differences between Full and Partial Agonists: Evidence for Ligand-Specific Receptor Conformations J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1218 - 1226. [Abstract] [Full Text]
|
|
|
|
|
|
F. Y. Carroll, A. Stolle, P. M. Beart, A. Voerste, I. Brabet, F. Mauler, C. Joly, H. Antonicek, J. Bockaert, T. Müller, et al. BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity. Mol. Pharmacol., April 16, 2001; 59(5): 965 - 973. [Abstract] [Full Text]
|
|
|
|
|
|
C. Watson, G. Chen, P. Irving, J. Way, W.-J. Chen, and T. Kenakin The Use of Stimulus-Biased Assay Systems to Detect Agonist-Specific Receptor Active States: Implications for the Trafficking of Receptor Stimulus by Agonists Mol. Pharmacol., April 13, 2001; 58(6): 1230 - 1238. [Abstract] [Full Text]
|
|
|
|
|
|
M. Waelbroeck Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 2. Testing the "Two-States" Model of Receptor Activation Mol. Pharmacol., April 1, 2001; 59(4): 886 - 893. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wade, K.-L. Lan, D. J. Moore, and R. R. Neubig Inverse Agonist Activity at the {alpha}2A-Adrenergic Receptor Mol. Pharmacol., March 1, 2001; 59(3): 532 - 542. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-Y. Zhou, D. Yang, W.-Z. Zhu, S.-J. Zhang, D.-J. Wang, D. K. Rohrer, E. Devic, B. K. Kobilka, E. G. Lakatta, H. Cheng, et al. Spontaneous Activation of beta 2- but Not beta 1-Adrenoceptors Expressed in Cardiac Myocytes from beta 1beta 2 Double Knockout Mice Mol. Pharmacol., November 1, 2000; 58(5): 887 - 894. [Abstract] [Full Text]
|
|
|
|
|
|
S. Claeysen, M. Sebben, C. Bécamel, R. M. Eglen, R. D. Clark, J. Bockaert, and A. Dumuis Pharmacological Properties of 5-Hydroxytryptamine4 Receptor Antagonists on Constitutively Active Wild-Type and Mutated Receptors Mol. Pharmacol., July 1, 2000; 58(1): 136 - 144. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Durr, J. Hensen, T. Ehnis, and M. S. Blankenship Chlorpropamide upregulates antidiuretic hormone receptors and unmasks constitutive receptor signaling Am J Physiol Renal Physiol, May 1, 2000; 278(5): F799 - F808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Rosenkilde and T. W. Schwartz Potency of Ligands Correlates with Affinity Measured against Agonist and Inverse Agonists but Not against Neutral Ligand in Constitutively Active Chemokine Receptor Mol. Pharmacol., March 1, 2000; 57(3): 602 - 609. [Abstract] [Full Text]
|
|
|
|
 |
|
 U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text]
|
|
|
|
|
|
O. Rossier, L. Abuin, F. Fanelli, A. Leonardi, and S. Cotecchia Inverse Agonism and Neutral Antagonism at alpha 1a- and alpha 1b-Adrenergic Receptor Subtypes Mol. Pharmacol., November 1, 1999; 56(5): 858 - 866. [Abstract] [Full Text]
|
|
|
|
|
|
G. Cai, H. Gurdal, C. Smith, H.-Y. Wang, and E. Friedman Inverse Agonist Properties of Dopaminergic Antagonists at the D1A Dopamine Receptor: Uncoupling of the D1A Dopamine Receptor from Gs Protein Mol. Pharmacol., November 1, 1999; 56(5): 989 - 996. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-Y. Zhou, H. Cheng, L.-S. Song, D. Wang, E. G. Lakatta, and R.-P. Xiao Spontaneous beta 2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes Mol. Pharmacol., September 1, 1999; 56(3): 485 - 493. [Abstract] [Full Text]
|
|
|
|
|
|
R. Seifert, U. Gether, K. Wenzel-Seifert, and B. K. Kobilka Effects of Guanine, Inosine, and Xanthine Nucleotides on beta 2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations Mol. Pharmacol., August 1, 1999; 56(2): 348 - 358. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bouaboula, D. Dussossoy, and P. Casellas Regulation of Peripheral Cannabinoid Receptor CB2 Phosphorylation by the Inverse Agonist SR 144528. IMPLICATIONS FOR RECEPTOR BIOLOGICAL RESPONSES J. Biol. Chem., July 16, 1999; 274(29): 20397 - 20405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G.F. Rasmussen, A. D. Jensen, G. Liapakis, P. Ghanouni, J. A. Javitch, and U. Gether Mutation of a Highly Conserved Aspartic Acid in the beta 2 Adrenergic Receptor: Constitutive Activation, Structural Instability, and Conformational Rearrangement of Transmembrane Segment 6 Mol. Pharmacol., July 1, 1999; 56(1): 175 - 184. [Abstract] [Full Text]
|
|
|
|
|
|
S. Claeysen, M. Sebben, C. Becamel, J. Bockaert, and A. Dumuis Novel Brain-Specific 5-HT4 Receptor Splice Variants Show Marked Constitutive Activity: Role of the C-Terminal Intracellular Domain Mol. Pharmacol., May 1, 1999; 55(5): 910 - 920. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bouaboula, N. Desnoyer, P. Carayon, T. Combes, and P. Casellas Gi Protein Modulation Induced by a Selective Inverse Agonist for the Peripheral Cannabinoid Receptor CB2: Implication for Intracellular Signalization Cross-Regulation. Mol. Pharmacol., March 1, 1999; 55(3): 473 - 480. [Abstract] [Full Text]
|
|
|
|
|
|
M. Portier, M. Rinaldi-Carmona, F. Pecceu, T. Combes, C. Poinot-Chazel, B. Calandra, F. Barth, G. L. Fur, and P. Casellas SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 582 - 589. [Abstract] [Full Text]
|
|
|
|
|
|
X. Pan, S. R. Ikeda, and D. L. Lewis SR 141716A Acts as an Inverse Agonist to Increase Neuronal Voltage-Dependent Ca2+ Currents by Reversal of Tonic CB1 Cannabinoid Receptor Activity Mol. Pharmacol., December 1, 1998; 54(6): 1064 - 1072. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Serre, W. Dolci, E. Schaerer, L. Scrocchi, D. Drucker, S. Efrat, and B. Thorens Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and {beta}-Cell Glucose Competence Endocrinology, November 1, 1998; 139(11): 4448 - 4454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Burstein, T. A. Spalding, and M. R. Brann The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling J. Biol. Chem., September 18, 1998; 273(38): 24322 - 24327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gether and B. K. Kobilka G Protein-coupled Receptors. II. MECHANISM OF AGONIST ACTIVATION J. Biol. Chem., July 17, 1998; 273(29): 17979 - 17982. [Full Text] [PDF]
|
